StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
2913.TW$11.30+1.80%
Fair $11.30+0.0%

2913.TW

Taiwan Tea Corporation

Consumer Defensive / Farm ProductsTaiwan

$11.30

+0.20 (+1.80%)

Fairly Valued+0.0%Fair Value $11.30Fund rank 25/100 · Data gapFallback financials|
SA 22/D
F-Score: 5/9
Low Profitability

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 34% · confianza 17%

FCF escenarios

weak_data · normalized FCF $37.3M · quality 40.7/100

Data gap 25/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 13/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

22/100

D

Piotroski

5/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 1unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Insufficient audited annual history (<3 SEC-backed years); composite fair value and forward targets are disabled until manually verified. ROE is -0.9%, below the 5% threshold
Thesis & Journal · 2913.TWLocal privado en este navegador · Taiwan Tea Corporation
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$8.9B

P/E

N/A

•

EV/EBITDA

126.6x

↑

ROE

-0.9%

↓

Gross Margin

38.6%

↑

Debt/Equity

0.42

↑
52-Week Range$11
$11$17

TradingView lightweight chart

2913.TW price, volumen y niveles de valoración

Último $11.30Periodo -89.1%
Fair value: $11.30

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

+7.8%

FCF CAGR

—

FCF margin

7.9%

FCF / Net income

-0.32x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $472.7M · net income $-116.2M · FCF $37.3M

2022-FY → 2025-FY

Gross margin

38.6%-5.1% pts

Operating margin

-4.1%+36.9% pts

Net margin

-24.6%+409.1% pts

FCF margin

7.9%+80.2% pts
MetricTTM
2025
2024
2023
2022
Income Statement
Revenue$472.7M$472.7M$433.1M$379.5M$377.0M
Net Income$-116.2M$-116.2M$-175.1M$-287.5M$-1.64B
EBITDA$111.2M$111.2M$53.2M$-73.2M$-1.38B
EPS——-0.22-0.36-2.07
Gross Margin38.6%38.6%37.4%36.4%43.7%
Operating Margin-4.1%-4.1%-14.0%-32.8%-41.0%
Net Margin-24.6%-24.6%-40.4%-75.7%-433.7%
Balance Sheet
Debt/Equity0.420.420.410.410.43
Current Ratio1.021.02———
Cash Flow
Free Cash Flow$37.3M$37.3M$89.8M$-69.5M$-272.7M
Returns
ROE-0.9%-0.9%-1.4%-2.3%-12.6%
Valuation
EV/EBITDA126.59126.59391.70——
P/B0.720.721.261.321.30
Growth & Yield
Revenue Growth9.1%9.1%14.1%0.7%—
EPS Growth——38.9%82.6%—

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%
Reverse DCF requires positive EPS; loss-making or zero-EPS companies cannot produce a clean EPS hurdle.

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total -32.1%

Total return

-32.1%

Start / end P/E

n/dx → n/dx

EPS bridge

-0.22 → n/d

Residual

-32.1%

EPS growthn/d
Multiple reratingn/d
Dividend+0.0%
Residual / FX / buybacks / cross-term-32.1%

EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.